Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherIMMUNOPHARMACOLOGY

Pharmacological Effects of SB 220025, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models

Jeffrey R. Jackson, Brian Bolognese, Leonard Hillegass, Shouki Kassis, Jerry Adams, Don E. Griswold and James D. Winkler
Journal of Pharmacology and Experimental Therapeutics February 1998, 284 (2) 687-692;
Jeffrey R. Jackson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Bolognese
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Hillegass
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shouki Kassis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Adams
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Don E. Griswold
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James D. Winkler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 284 no. 2 687-692
PubMed 
9454815

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received June 11, 1997
  • Accepted October 17, 1997
  • Published online February 1, 1998.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jeffrey R. Jackson1,
  2. Brian Bolognese1,
  3. Leonard Hillegass1,
  4. Shouki Kassis2,
  5. Jerry Adams3,
  6. Don E. Griswold1 and
  7. James D. Winkler1
  1. 1From the Departments of Immunopharmacology (J.R.J., B.B., L.H., D.E.G., J.D.W.), 2Cellular Biochemistry (S.K.) and 3Medicinal Chemistry (J.A.), SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: January 1999 to January 2021

    AbstractFullPdf
    Jan 199911312
    Feb 1999153
    Mar 19992157
    Apr 199921317
    May 199921011
    Jun 19991106
    Jul 199911824
    Aug 1999145
    Sep 199911916
    Oct 199941733
    Nov 199951623
    Dec 1999232
    Jan 200014832
    Feb 200011922
    Mar 200022124
    Apr 200011415
    May 200083044
    Jun 200012860
    Jul 200031636
    Aug 200001940
    Sep 200001527
    Oct 200021748
    Nov 200022921
    Dec 200011530
    Jan 200112125
    Feb 200102543
    Mar 200163232
    Apr 200123140
    May 200112137
    Jun 200112234
    Jul 200142448
    Aug 200122421
    Sep 200131922
    Oct 200111318
    Nov 200171525
    Dec 200131920
    Jan 200221333
    Feb 200231529
    Mar 200282032
    Apr 200213828
    May 200252850
    Jun 200242138
    Jul 200211936
    Aug 200272763
    Sep 200211915
    Oct 200232442
    Nov 20023921
    Dec 200203250
    Jan 200323141
    Feb 200303947
    Mar 200342331
    Apr 200342431
    May 200332547
    Jun 200312523
    Jul 200393115
    Aug 2003155137
    Sep 200373834
    Oct 2003124029
    Nov 2003132812
    Dec 2003164829
    Jan 2004184941
    Feb 2004235148
    Mar 2004165741
    Apr 2004214640
    May 2004154627
    Jun 2004183427
    Jul 2004204023
    Aug 2004273932
    Sep 2004152820
    Oct 2004184022
    Nov 2004164230
    Dec 2004184033
    Jan 2005156142
    Feb 2005205920
    Mar 2005204420
    Apr 200544524
    May 200562716
    Jun 2005113114
    Jul 200532317
    Aug 200593125
    Sep 200584220
    Oct 200582613
    Nov 2005115123
    Dec 200554716
    Jan 20066474
    Feb 200687923
    Mar 20065399
    Apr 200664313
    May 2006155729
    Jun 200684020
    Jul 2006112818
    Aug 2006134230
    Sep 200684720
    Oct 2006135826
    Nov 200675222
    Dec 200663011
    Jan 200793514
    Feb 2007103017
    Mar 200783315
    Apr 200796918
    May 200754419
    Jun 2007115320
    Jul 200782311
    Aug 200785619
    Sep 2007104913
    Oct 200766018
    Nov 200725622
    Dec 20071339
    Jan 200824117
    Feb 200863223
    Mar 200845122
    Apr 200896725
    May 2008104313
    Jun 200823116
    Jul 200853620
    Aug 200852814
    Sep 200884115
    Oct 200884317
    Nov 200893918
    Dec 2008113411
    Jan 200923516
    Feb 200925316
    Mar 200945616
    Apr 2009145929
    May 200985723
    Jun 200995211
    Jul 200995316
    Aug 200985013
    Sep 2009126424
    Oct 20094387
    Nov 2009101515
    Dec 2009141710
    Jan 2010104218
    Feb 2010105222
    Mar 2010125415
    Apr 2010105813
    May 201034614
    Jun 201004615
    Jul 2010147625
    Aug 201094717
    Sep 201043916
    Oct 201064725
    Nov 20102316
    Dec 201013115
    Jan 201153116
    Feb 20112259
    Mar 201172719
    Apr 201192719
    May 2011172718
    Jun 201182018
    Jul 201132215
    Aug 2011161214
    Sep 2011112011
    Oct 2011153216
    Nov 201184326
    Dec 2011133619
    Jan 201282017
    Feb 201273019
    Mar 2012293420
    Apr 2012242421
    May 2012153719
    Jun 2012131310
    Jul 201291212
    Aug 20123139
    Sep 20127717
    Oct 2012141113
    Nov 20128117
    Dec 2012585
    Jan 201381311
    Feb 20137715
    Mar 20139105
    Apr 20137187
    May 20138914
    Jun 20135918
    Jul 2013997
    Aug 2013133
    Sep 2013434
    Oct 20138610
    Nov 20137715
    Dec 2013355
    Jan 2014471
    Feb 2014516
    Mar 2014564
    Apr 2014547
    May 2014268
    Jun 2014569
    Jul 2014131114
    Aug 2014468
    Sep 2014543
    Oct 2014146
    Nov 20149105
    Dec 2014143
    Jan 2015461112
    Feb 2015747
    Mar 2015463
    Apr 2015532
    May 2015514
    Jun 2015266
    Jul 2015425
    Aug 2015225
    Sep 2015261
    Oct 20153739
    Nov 2015246
    Dec 2015560
    Jan 2016515
    Feb 2016865
    Mar 20167814
    Apr 20161913
    May 20169611
    Jun 2016847
    Jul 20160612
    Aug 20167312
    Sep 2016446
    Oct 2016085
    Nov 2016147
    Dec 2016174
    Jan 20171117
    Feb 2017574
    Mar 2017252
    Apr 2017259
    May 20170218
    Jun 2017061
    Jul 2017198
    Aug 2017555
    Sep 2017055
    Oct 2017053
    Nov 20179101
    Dec 20171668
    Jan 20181292
    Feb 2018774
    Mar 201810115
    Apr 20187143
    May 20188114
    Jun 201814143
    Jul 2018861
    Aug 20181081
    Sep 20185311
    Oct 20186817
    Nov 20181848
    Dec 20181111
    Jan 2019910
    Feb 20191401
    Mar 2019610
    Apr 2019800
    May 20191111
    Jun 2019112
    Jul 2019400
    Aug 2019720
    Sep 20191020
    Oct 20191640
    Nov 20191620
    Dec 20191700
    Jan 2020521
    Feb 2020700
    Mar 2020511
    Apr 2020401
    May 20202011
    Jun 2020711
    Jul 2020910
    Aug 2020702
    Sep 20202140
    Oct 20201611
    Nov 20202310
    Dec 20201630
    Jan 2021210

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 284, Issue 2
    1 Feb 1998
    • Table of Contents
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Pharmacological Effects of SB 220025, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    OtherIMMUNOPHARMACOLOGY

    Pharmacological Effects of SB 220025, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models

    Jeffrey R. Jackson, Brian Bolognese, Leonard Hillegass, Shouki Kassis, Jerry Adams, Don E. Griswold and James D. Winkler
    Journal of Pharmacology and Experimental Therapeutics February 1, 1998, 284 (2) 687-692;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    OtherIMMUNOPHARMACOLOGY

    Pharmacological Effects of SB 220025, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models

    Jeffrey R. Jackson, Brian Bolognese, Leonard Hillegass, Shouki Kassis, Jerry Adams, Don E. Griswold and James D. Winkler
    Journal of Pharmacology and Experimental Therapeutics February 1, 1998, 284 (2) 687-692;
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Modulation of Mouse Endotoxin Shock by Inhibition of Phosphatidylcholine-Specific Phospholipase C
    • IL-10 Synergizes with Dexamethasone in Inhibiting Human T Cell Proliferation
    • Spontaneous and Cationic Lipid-Mediated Uptake of Antisense Oligonucleotides in Human Monocytes and Lymphocytes
    Show more IMMUNOPHARMACOLOGY

    Similar Articles

    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics